Targeting Prostate Cancer Using Intratumoral Cytotopically Modified Interleukin-15 Immunotherapy in a Syngeneic Murine Model

Efthymia Papaevangelou,1 Dorota Smolarek,1 Richard A Smith,1 Prokar Dasgupta,1,2 Christine Galustian1 1Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King’s College London, Guy’s Hospital, London, UK; 2Urology Centre, Guy’s Hospital, London, U...

Descripció completa

Dades bibliogràfiques

Autors principals:	Papaevangelou E, Smolarek D, Smith RA, Dasgupta P, Galustian C
Format:	Artigo
Idioma:	Inglês
Publicat:	Dove Medical Press 2020-07-01
Col·lecció:	ImmunoTargets and Therapy
Matèries:	il-15 checkpoint blockade prostate cancer cytotopic modification nk cells
Accés en línia:	https://www.dovepress.com/targeting-prostate-cancer-using-intratumoral-cytotopically-modified-in-peer-reviewed-article-ITT
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!